Kay Ohlendieck

10.0k total citations · 1 hit paper
223 papers, 8.2k citations indexed

About

Kay Ohlendieck is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Kay Ohlendieck has authored 223 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Molecular Biology, 109 papers in Cell Biology and 66 papers in Physiology. Recurrent topics in Kay Ohlendieck's work include Muscle Physiology and Disorders (142 papers), Muscle metabolism and nutrition (68 papers) and Adipose Tissue and Metabolism (51 papers). Kay Ohlendieck is often cited by papers focused on Muscle Physiology and Disorders (142 papers), Muscle metabolism and nutrition (68 papers) and Adipose Tissue and Metabolism (51 papers). Kay Ohlendieck collaborates with scholars based in Ireland, Germany and United States. Kay Ohlendieck's co-authors include Kevin P. Campbell, James M. Ervasti, Steven D. Kahl, Paul Dowling, Dieter Swandulla, Philip Doran, Kiichiro Matsumura, Margit Zweyer, Sandra Murphy and Kathleen O’Connell and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Neuron.

In The Last Decade

Kay Ohlendieck

220 papers receiving 8.1k citations

Hit Papers

Deficiency of a glycoprotein component of the dystrophin ... 1990 2026 2002 2014 1990 250 500 750

Peers

Kay Ohlendieck
Stanley C. Froehner United States
Steven D. Kahl United States
Kristine E. Kamm United States
James R. Florini United States
Noah Weisleder United States
Stanley C. Froehner United States
Kay Ohlendieck
Citations per year, relative to Kay Ohlendieck Kay Ohlendieck (= 1×) peers Stanley C. Froehner

Countries citing papers authored by Kay Ohlendieck

Since Specialization
Citations

This map shows the geographic impact of Kay Ohlendieck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Ohlendieck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Ohlendieck more than expected).

Fields of papers citing papers by Kay Ohlendieck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Ohlendieck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Ohlendieck. The network helps show where Kay Ohlendieck may publish in the future.

Co-authorship network of co-authors of Kay Ohlendieck

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Ohlendieck. A scholar is included among the top collaborators of Kay Ohlendieck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Ohlendieck. Kay Ohlendieck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowling, Paul, Capucine Trollet, Elisa Négroni, Dieter Swandulla, & Kay Ohlendieck. (2024). How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?. Proteomes. 12(1). 4–4. 4 indexed citations
2.
Dowling, Paul, Margit Zweyer, Hemmen Sabir, et al.. (2023). Mass spectrometry-based proteomic characterization of the middle-aged mouse brain for animal model research of neuromuscular diseases. European Journal of Translational Myology. 33(3). 2 indexed citations
3.
Dowling, Paul, et al.. (2020). Identification of marker proteins of muscular dystrophy in the urine proteome from the mdx-4cv model of dystrophinopathy. Molecular Omics. 16(3). 268–278. 15 indexed citations
4.
Dowling, Paul, et al.. (2020). Proteomic profiling of fatty acid binding proteins in muscular dystrophy. Expert Review of Proteomics. 17(2). 137–148. 16 indexed citations
5.
Dowling, Paul, Margit Zweyer, Michael Henry, et al.. (2020). Proteome-wide Changes in the mdx-4cv Spleen due to Pathophysiological Cross Talk with Dystrophin-Deficient Skeletal Muscle. iScience. 23(9). 101500–101500. 24 indexed citations
6.
Dowling, Paul, et al.. (2019). Emerging proteomic biomarkers of X-linked muscular dystrophy. Expert Review of Molecular Diagnostics. 19(8). 739–755. 27 indexed citations
7.
Murphy, Sandra, Margit Zweyer, Michael Henry, et al.. (2018). Subproteomic profiling of sarcolemma from dystrophic mdx-4cv skeletal muscle. Data in Brief. 17. 980–993. 6 indexed citations
8.
Dowling, Paul & Kay Ohlendieck. (2017). DIGE Analysis of Immunodepleted Plasma. Methods in molecular biology. 1664. 245–257. 5 indexed citations
9.
Murphy, Sandra & Kay Ohlendieck. (2017). Proteomic profiling of large myofibrillar proteins from dried and long-term stored polyacrylamide gels. Analytical Biochemistry. 543. 8–11. 17 indexed citations
10.
Dowling, Paul, Ashling Holland, & Kay Ohlendieck. (2014). Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies. Journal of Neuromuscular Diseases. 1(1). 15–40. 23 indexed citations
11.
Dowling, Paul, et al.. (2013). Naturally Protected Muscle Phenotypes: Development of Novel Treatment Strategies for Duchenne Muscular Dystrophy. MURAL - Maynooth University Research Archive Library (National University of Ireland, Maynooth). 1 indexed citations
12.
Staunton, Lisa, et al.. (2011). Identification of secondary effects of hyperexcitability by proteomic profiling of myotonic mouse muscle. Molecular BioSystems. 7(8). 2480–2489. 17 indexed citations
13.
Ohlendieck, Kay. (2011). Proteomic profiling of fast-to-slow muscle transitions during aging. Frontiers in Physiology. 2. 105–105. 56 indexed citations
14.
Lewis, Caroline A., Philip Doran, & Kay Ohlendieck. (2011). Proteomic Analysis of Dystrophic Muscle. Methods in molecular biology. 798. 357–369. 14 indexed citations
15.
Doran, Philip, Joan Gannon, Kathleen O’Connell, & Kay Ohlendieck. (2007). Proteomic profiling of animal models mimicking skeletal muscle disorders. PROTEOMICS - CLINICAL APPLICATIONS. 1(9). 1169–1184. 32 indexed citations
16.
Wilson, Keith, John R. Walker, K. Wilson, et al.. (2005). Principles and Techniques of Biochemistry and Molecular Biology. Cambridge University Press eBooks. 119 indexed citations
17.
Ohlendieck, Kay, et al.. (2004). Drastic reduction in the luminal Ca2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1689(3). 252–258. 24 indexed citations
18.
Ohlendieck, Kay. (2003). Removal of Detergent from Protein Fractions. Humana Press eBooks. 59. 305–312. 5 indexed citations
19.
Glover, Louise, Kevin Culligan, Steven E. Cala, Claire M. Mulvey, & Kay Ohlendieck. (2001). Calsequestrin binds to monomeric and complexed forms of key calcium-handling proteins in native sarcoplasmic reticulum membranes from rabbit skeletal muscle. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1515(2). 120–132. 25 indexed citations
20.
Ohlendieck, Kay, Jacqueline S. Partin, Robin L. Stears, & William J. Lennarz. (1994). Developmental Expression of the Sea Urchin Egg Receptor for Sperm. Developmental Biology. 165(1). 53–62. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026